https://www.selleckchem.com/pr....oducts/palazestrant.
693 (95% CI, 0.628 to 0.758). The model presented with good prediction accuracy in both training cohort and validation cohort. We developed a convenient clinical prediction model for regional lymph node metastases in NSCLC patients. The nomogram will help physicians to determine which patients will receive the most benefit from lymph node dissection. We developed a convenient clinical prediction model for regional lymph node metastases in NSCLC patients. The nomogram will help physicians to determine which patients will receive the
Like
Comment
Share
